Ceapro Inc V.CZO

Imagine

[boazklinghorn]

Imagine a deal between 2 companies  which together are burning  over 5 million a quarter. Both of which have seen shareholders destroyed for over a decade. Imagine the man who was resposible for all that destruction wanted to merge them and run them with no board of directors to protect shareholders. Who, knowing all this would say yes I will take a peice of that action. Nobody ever would.  
Proph is a an agent provactuer he wants you to bend over while Gilles whispers the same BS in your ear that he has done for the last 10 years. If you vote for this deal you deserve every inch of the painful experience that will inevitabley follow. 
Remember, Gilles wants this done before he has to show shareholders the destruction he has wrought in Q4 pursuing this ridiculous deal.  You have been warned. 
Now imagine a new CEO young and keen who actually speaks english and cares enough to live in the same province that the company is based in.. A new team and a new regime where managment's every single action reflects the idea that they represent shareholders interests first last and always. Imagine quarterly calls and accountability. Imagine no more Jenene. Imagine deals happening and managment salaries tied to stock performance. This is not a dream people this exists, this is what we could have. If we stick together and vote these criminals out  we can all still get rich here.

[prophetoffactz]

"Imagine a deal between 2 companies  which together are burning  over 5 million a quarter." The Strongbridge licensing deal for AEZS's diagnostic had C$71 million in upfront cash and potential near-term payments plus royalties. AEZS is about to license the test again and is on the verge of potential approval for the tests most important market(children). Gilles is on the

[boazklinghorn]

Good work Proph keep slathering on the vaseline, Gilles is coming... Woooooo...

[boazklinghorn]

Imagine a web page updated to get rid of the two old geezers on the beach. What message are we selling with that? Imagine analyst coverage. Imagine an investor day. Imagine energy and drive coming from the Csuite instead of secrecy. Imagine a deal for a development partnership or any kind of collaboration with an actual PharmaCo. All of this exists. We just need to demand it. 

[Tencents]

It was easy for Stonebridge to agree 71m knowing the 24 m upfront would never be paid and the milestones had sales levels well beyond realistic  achievable - experts had sales levels at something like 5 to 10 m annually if ever the product is relaunched the numbers will probably be only sufficient to support todays Sp 

[prophetoffactz]

Tencents says: It was easy for Stonebridge to agree C71m knowing the US24 m upfront would never be paid...   "Under the terms of the license and assignment agreement, Strongbridge will make an upfront payment of $24 million to Aeterna Zentaris within five days of the effective date of the agreement." Strongbridge news release  That's C$32 million alone upfront. When its

[prophetoffactz]

AEZS's diagnostic test deal with Strongbridge was signed 6 years ago this month. Using US CPI to adjust for inflation the US$24 million upfront AEZS received would now be equal to US$29.39 million or C$39.7 million adjusted for inflation. 

[prophetoffactz]

Gilles Gagnon, Chief Executive Officer of Ceapro “The transaction provides us with the additional capital and internal capabilities to fully support near-term revenue generating cosmeceutical and nutraceutical product development programs..." December news release The merger provides the capital to near-term revenue generating opportunities.

[prophetoffactz]

The capital to FULLY support near-term revenue generating opportunities.

[Tencents]

At what period do we see the 24 m booked in the financial report of aezs 

[prophetoffactz]

AEZS booked the US$24 million upfront payment from Strongbridge as earned revenue in the very same quarter as the licensing deal was signed six years ago. Adjusted for inflation that is C$39.7 million upfront cash for the upfront payment alone with approval for the key childhood market still an expected 3-4 years and a clinical trial away. The test could be approved for children this year. That